3KUTER DJ,BEGLEY CG. Recombinant human thrombopoietin:Basic bioloth and evaluation ofclinical studies [J] .Blood,2002;Nov15:100(10):3457-3469.
4Kienast J,Schmitz G. Flow cytometric analysis of thiazole orange uptake by platelets:a diagnostic aid in the evaluation of thrombocytopenic patients[J].Blood,1990,(02):116-120.
5Saxon BR,Mody M,Blanchette VS. Reticulated platelet counts in the assessment of throm bocytopenic disorders[J].Acta Paediatrica Supplement,1998,(01):65-70.
6Takubo T,Yamane T,Hino M. Clinical significance of simultaneous measurement of reticulated platelets and large platelets in idiopathic thrombocytopenic purpura[J].Haematologia(Budap),2000,(03):183-192.
7Robinson MSC,Mackie IJ,Khair K. Flowcytometric analysis of reticulated platelet:evidence for a large proportion of non-specific labeling of dense granules by fluorent dyes[J].British Journal of Haematology,1998,(02):351-357.doi:10.1046/j.1365-2141.1998.00563.x.
8Bonan JL,Rinder HM,Smith BR. Determination of the percentage of thiozole orange(TO) positive reticulated platelets using autologous erythrocyte TO fluorescence as an internal standard[J].Cytometry,1993,(04):690-695.
9Schimitz G,Rothe G,Ruf A. European group on clinical cell analysis:consensus protocol for the flowcytometric characterization of platelet function[J].Thrombosis and Haemostasis,1998,(07):885-896.
